@article{28e5cb60c2b9406eb7940e877e51e479,
title = "No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic",
abstract = "NA",
keywords = "Betacoronavirus, Biological Products, COVID-19, Coronavirus Infections, Humans, Immunosuppressive Agents, Italy, Pandemics, Pneumonia, Viral, Receptors, Interleukin-6, Respiration Disorders, Rheumatic Diseases, Risk Factors, SARS-CoV-2, Betacoronavirus, Biological Products, COVID-19, Coronavirus Infections, Humans, Immunosuppressive Agents, Italy, Pandemics, Pneumonia, Viral, Receptors, Interleukin-6, Respiration Disorders, Rheumatic Diseases, Risk Factors, SARS-CoV-2",
author = "Stefano Alivernini and Luca Petricca and Simone Perniola and Fedele, \{Anna Laura\} and Gigante, \{Maria Rita\} and Annunziata Capacci and Annamaria Paglionico and Valentina Varriano and \{De Lorenzis\}, Enrico and Lucia Lanzo and Fabrizio Melpignano and Pietro Rubortone and Giacomo Tanti and Carlo Tur and Dario Bruno and Laura Gigante and Gerlando Natalello and Lucrezia Verardi and \{Di Mario\}, Clara and Barbara Tolusso and Luisa Mirone and Lizzio, \{Marco Maria\} and Angelo Zoli and Giusy Peluso and Bosello, \{Silvia Laura\} and Elisa Gremese and Elisa Gremese",
year = "2020",
doi = "10.1093/rheumatology/keaa388",
language = "English",
volume = "59",
pages = "2644--2646",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
}